| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |